Danger, diversity and priming in innate antiviral immunity

Cytokine and Growth Factor Reviews

Volumn 25, Issue 5, 2014, Pages 525-531

  Collins, Susan E ^a   Mossman, Karen L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Danger; Interferon regulatory factors; Interferon independent; Intrinsic and innate immunity; Priming

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERLEUKIN 13; INTERLEUKIN 4; PATTERN RECOGNITION RECEPTOR; STAT6 PROTEIN; HEAT SHOCK PROTEIN;

ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; CELL SURFACE; CELLULAR STRESS RESPONSE; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENDOPLASMIC RETICULUM STRESS; GENE INDUCTION; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTRACELLULAR SPACE; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PHYSIOLOGY; VIRUS;

ANIMALS; HEAT-SHOCK PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERONS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; VIRUS DISEASES; VIRUSES;

EID: 84908318788     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2014.07.002     Document Type: Short Survey

References (86)

1. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., Ross S.R. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc Natl Acad Sci USA 2002, 99:2281-2286.
2. Bieback K., Lien E., Klagge I.M., Avota E., Schneider-Schaulies J., Duprex W.P., et al. Hemagglutinin protein of wild-type measles virus activates Toll-like receptor 2 signaling. J Virol 2002, 76:8729-8736.
3. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003, 77:4588-4596.
4. Goubau D., Deddouche S., Reis e Sousa C. Cytosolic sensing of viruses. Immunity 2013, 38:855-869.
5. Jensen S., Thomsen A.R. Sensing of RNA viruses: a review of innate immune receptors involved in recognizing RNA virus invasion. J Virol 2012, 86:2900-2910.
6. Gack M.U. Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens. J Virol 2014, 88:5213-5216.
7. Taylor K.E., Mossman K.L. Recent advances in understanding viral evasion of type I interferon. Immunology 2013, 138:190-197.
8. Hare D., Mossman K.L. Novel paradigms of innate immune sensing of viral infections. Cytokine 2013, 63:219-224.
9. Paladino P., Cummings D.T., Noyce R.S., Mossman K.L. The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 2006, 177:8008-8016.
10. Davies M.L., Sei J.J., Siciliano N.A., Xu R.H., Roscoe F., Sigal L.J., et al. MyD88-dependent immunity to a natural model of vaccinia virus infection does not involve Toll-like receptor 2. J Virol 2014, 88:3557-3567.
11. Sato S., St-Pierre C., Bhaumik P., Nieminen J. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs). Immunol Rev 2009, 230:172-187.
12. Kelley J.L., Ozment T.R., Li C., Schweitzer J.B., Williams D.L. Scavenger receptor-A (CD204): a two-edged sword in health and disease. Crit Rev Immunol 2014, 34:241-261.
13. Giannia T.L.V., Chesnokovab L.S., Hutt-Fletcherb L.M., Campadelli-Fiumea G. αVβ3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1. Proc Natl Acad Sci USA 2012, 109:19792-19797.
14. Hotter D., Sauter D., Kirchhoff F. Emerging role of the host restriction factor tetherin in viral immune sensing. J Mol Biol 2013, 425:4956-4964.
15. Le Tortorec A., Willey S., Neil S.J. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 2011, 3:520-540.
16. Mossman K.L., Macgregor P.F., Rozmus J.J., Goryachev A.B., Edwards A.M., Smiley J.R. Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 2001, 75:750-758.
17. Preston C.M., Harman A.N., Nicholl M.J. Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 2001, 75:8909-8916.
18. Netterwald J.R., Jones T.R., Britt W.J., Yang S.J., McCrone I.P., Zhu H. Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus. J Virol 2004, 78:6688-6691.
19. Lester S.N., Li K. Toll-like receptors in antiviral innate immunity. J Mol Biol 2014, 426:1246-1264.
20. Rigby R.E., Webb L.M., Mackenzie K.J., Li Y., Leitch A., Reijns M.A., et al. RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. EMBO J 2014, 33:542-558.
21. Fitzgerald M.E., Rawling D.C., Vela A., Pyle A.M. An evolving arsenal: viral RNA detection by RIG-I-like receptors. Curr Opin Microbiol 2014, 20C:76-81.
22. Jacobs B.L., Langland J.O. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996, 219:339-349.
23. Paludan S.R., Bowie A.G. Immune sensing of DNA. Immunity 2013, 38:870-880.
24. Unterholzner L. The interferon response to intracellular DNA: why so many receptors. Immunobiology 2013, 218:1312-1321.
25. Unterholzner L., Keating S.E., Baran M., Horan K.A., Jensen S.B., Sharma S., et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol 2010, 11:997-1004.
26. Morrone S.R., Wang T., Constantoulakis L.M., Hooy R.M., Delannoy M.J., Sohn J. Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy. Proc Natl Acad Sci USA 2014, 111:E62-E71.
27. Zinzula L., Tramontano E. Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. Antiviral Res 2013, 100:615-635.
28. Paladino P., Mossman K.L. Mechanisms employed by the herpes simplex virus 1 to inhibit the interferon response. J Interferon Cytokine Res: Off J Int Soc Interferon Cytokine Res 2009, 29:599-607.
29. Taylor M.P., Koyuncu O.O., Enquist L.W. Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol 2011, 9:427-439.
30. Ivanovic T., Boulant S., Ehrlich M., Demidenko A.A., Arnold M.M., Kirchhausen T., et al. Recruitment of cellular clathrin to viral factories and disruption of clathrin-dependent trafficking. Traffic 2011, 12:1179-1195.
31. Holm C.K., Jensen S.B., Jakobsen M.R., Cheshenko N., Horan K.A., Moeller H.B., et al. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol 2012, 13:737-743.
32. Noyce R.S., Taylor K., Ciechonska M., Collins S.E., Duncan R., Mossman K.L. Membrane perturbation elicits an IRF3-dependent, interferon-independent antiviral response. J Virol 2011, 85:10926-10931.
33. Roizman B. Polykaryocytosis induced by viruses. Proc Natl Acad Sci USA 1962, 48:228-234.
34. Collins S.E., Noyce R.S., Mossman K.L. Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 2004, 78:1706-1717.
35. Noyce R.S., Collins S.E., Mossman K.L. Identification of a novel pathway essential for the immediate-early, interferon-independent antiviral response to enveloped virions. J Virol 2006, 80:226-235.
36. DeWitte-Orr S.J., Mehta D.R., Collins S.E., Suthar M.S., Gale M., Mossman K.L. Long double-stranded RNA induces an antiviral response independent of IFN regulatory factor 3, IFN-beta promoter stimulator 1, and IFN. J Immunol 2009, 183:6545-6553.
37. Bozym R.A., Delorme-Axford E., Harris K., Morosky S., Ikizler M., Dermody T.S., et al. Focal adhesion kinase is a component of antiviral RIG-I-like receptor signaling. Cell Host Microbe 2012, 11:153-166.
38. Jacobs J.L., Coyne C.B. Mechanisms of MAVS regulation at the mitochondrial membrane. J Mol Biol 2013, 425:5009-5019.
39. Kuroda E., Coban C., Ishii K.J. Particulate adjuvant and innate immunity: past achievements, present findings, and future prospects. Int Rev Immunol 2013, 32:209-220.
40. Iwasaki A., Medzhitov R. Regulation of adaptive immunity by the innate immune system. Science 2010, 327:291-295.
41. Sahdev P., Ochyl L.J., Moon J.J. Biomaterials for nanoparticle vaccine delivery systems. Pharm Res 2014, [Epub Ahead of Print].
42. Reder A.T., Feng X. Aberrant type I interferon regulation in autoimmunity: opposite directions in MS and SLE, shaped by evolution and body ecology. Front Immunol 2013, 4:281.
43. Hasan M., Koch J., Rakheja D., Pattnaik A.K., Brugarolas J., Dozmorov I., et al. Trex1 regulates lysosomal biogenesis and interferon-independent activation of antiviral genes. Nat Immunol 2013, 14:61-71.
44. Ablasser A., Hemmerling I., Schmid-Burgk J.L., Behrendt R., Roers A., Hornung V. TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. J Immunol 2014, 192(12):5993-5997.
45. Yan N., Regalado-Magdos A.D., Stiggelbout B., Lee-Kirsch M.A., Lieberman J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat Immunol 2010, 11:1005-1013.
46. Kavanagh D., Spitzer D., Kothari P.H., Shaikh A., Liszewski M.K., Richards A., et al. New roles for the major human 3'-5' exonuclease TREX1 in human disease. Cell Cycle (Georget, TX) 2008, 7:1718-1725.
47. Lucas-Hourani M., Dauzonne D., Jorda P., Cousin G., Lupan A., Helynck O., et al. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. PLOS Pathog 2013, 9:e1003678.
48. Pan Q., de Ruiter P.E., Metselaar H.J., Kwekkeboom J., de Jonge J., Tilanus H.W., et al. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C virus infection in vitro and in vivo. Hepatology 2012, 55:1673-1683.
49. Liu Y.P., Zeng L., Tian A., Bomkamp A., Rivera D., Gutman D., et al. Endoplasmic reticulum stress regulates the innate immunity critical transcription factor IRF3. J Immunol 2012, 189:4630-4639.
50. Smith J.A., Turner M.J., DeLay M.L., Klenk E.I., Sowders D.P., Colbert R.A. Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-beta induction via X-box binding protein 1. Eur J Immunol 2008, 38:1194-1203.
51. Zeng L., Liu Y.P., Sha H., Chen H., Qi L., Smith J.A. XBP-1 couples endoplasmic reticulum stress to augmented IFN-beta induction via a cis-acting enhancer in macrophages. J Immunol 2010, 185:2324-2330.
52. Wathelet M.G., Lin C.H., Parekh B.S., Ronco L.V., Howley P.M., Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol Cell 1998, 1:507-518.
53. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89:1-47.
54. Marie I., Durbin J.E., Levy D.E. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J 1998, 17:6660-6669.
55. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., Tanaka N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 1998, 441:106-110.
56. You F., Wang P., Yang L., Yang G., Zhao Y.O., Qian F., et al. ELF4 is critical for induction of type I interferon and the host antiviral response. Nat Immunol 2013, 14:1237-1246.
57. Prakash A., Smith E., Lee C.K., Levy D.E. Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 2005, 280:18651-18657.
58. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
59. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., et al. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 2000, 13:539-548.
60. Tsitoura E., Thomas J., Cuchet D., Thoinet K., Mavromara P., Epstein A.L. Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. J Gen Virol 2009, 90:2209-2220.
61. Noyce R.S., Collins S.E., Mossman K.L. Differential modification of interferon regulatory factor 3 following virus particle entry. J Virol 2009, 83:4013-4022.
62. Szabo A., Magyarics Z., Pazmandi K., Gopcsa L., Rajnavolgyi E., Bacsi A. TLR ligands upregulate RIG-I expression in human plasmacytoid dendritic cells in a type I IFN-independent manner. Immunol Cell Biol 2014, [Epub Ahead of Print].
63. Brownell J., Bruckner J., Wagoner J., Thomas E., Loo Y.-M., Gale M., et al. Direct, interferon-independent activation of the CXCL10 promoter by NF-kB and interferon regulatory factor 3 during hepatitis C virus infection. J Virol 2014, 88:1582-1590.
64. Olagnier D., Scholte F.E., Chiang C., Albulescu I.C., Nichols C., He Z., et al. Inhibition of dengue and chikungunya virus infection by RIG-I-mediated type I IFN-independent stimulation of the innate antiviral response. J Virol 2014, 88(8):4180-4194.
65. Noyce R., Paladino P., Mossman K.L. Interferon regulatory factor 3: a key regulator in the innate response to bacterial and viral pathogens. New research in innate immunity 2008, 261-299. Nova Science Publishers, Hauppauge, NY. M. Durand, C.V. Morel (Eds.).
66. Kato H., Takeuchi O., Mikamo-Satoh E., Hirai R., Kawai T., Matsushita K., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008, 205:1601-1610.
67. Prescott J.B., Hall P.R., Bondu-Hawkins V.S., Ye C., Hjelle B. Early innate immune responses to Sin Nombre Hantavirus occur independently of IFN regulatory factor 3, characterized pattern recognition receptors, and viral entry. J Immunol 2007, 179:1796-1802.
68. Takaki H., Honda K., Atarashi K., Kobayashi F., Ebihara T., Oshiumi H., et al. MAVS-dependent IRF3/7 bypass of interferon beta-induction restricts the response to measles infection in CD150Tg mouse bone marrow-derived dendritic cells. Mol Immunol 2014, 57:100-110.
69. Lazear H.M., Lancaster A., Wilkins C., Suthar M.S., Huang A., Vick S.C., et al. IRF-3, IRF-5, and IRF-7 coordinately regulate the type I IFN response in myeloid dendritic cells downstream of MAVS signaling. PLOS Pathog 2013, 9:e1003118.
70. Daffis S., Suthar M.S., Szretter K.J., Gale M., Diamond M.S. Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7. PLOS Pathog 2009, 5:e1000607.
71. Rubio D., Xu R.H., Remakus S., Krouse T.E., Truckenmiller M.E., Thapa R.J., et al. Crosstalk between the type 1 interferon and nuclear factor kappa B pathways confers resistance to a lethal virus infection. Cell Host Microbe 2013, 13:701-710.
72. Basagoudanavar S.H., Thapa R.J., Nogusa S., Wang J., Beg A.A., Balachandran S. Distinct roles for the NF-kappa B RelA subunit during antiviral innate immune responses. J Virol 2011, 85:2599-2610.
73. Nandakumar R., Finsterbusch K., Lipps C., Neumann B., Grashoff M., Nair S., et al. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms. Gastroenterology 2013, 145:1414 e1-1423 e1.
74. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., et al. Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-13 gene regulatory elements. Cell 1988, 54:903-913.
75. Stirnweiss A., Ksienzyk A., Klages K., Rand U., Grashoff M., Hauser H., et al. IFN regulatory factor-1 bypasses IFN-mediated antiviral effects through viperin gene induction. J Immunol 2010, 184:5179-5185.
76. Nair S., Michaelsen-Preusse K., Finsterbusch K., Stegemann-Koniszewski S., Bruder D., Grashoff M., et al. Interferon regulatory factor-1 protects from fatal neurotropic infection with vesicular stomatitis virus by specific inhibition of viral replication in neurons. PLOS Pathog 2014, 10(3):e1003999.
77. Dixit E., Boulant S., Zhang Y., Lee A.S., Odendall C., Shum B., et al. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 2010, 141:668-681.
78. Mehta D.R., Ashkar A.A., Mossman K.L. The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts. PLOS ONE 2012, 7:e31688.
79. Chen H., Sun H., You F., Sun W., Zhou X., Chen L., et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 2011, 147:436-446.
80. Wu J., Sun L., Chen X., Du F., Shi H., Chen C., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 2013, 339:826-830.
81. Sun L., Wu J., Du F., Chen X., Chen Z.J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 2013, 339:786-791.
82. Diner E.J., Burdette D.L., Wilson S.C., Monroe K.M., Kellenberger C.A., Hyodo M., et al. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING. Cell Rep 2013, 3:1355-1361.
83. Ablasser A., Schmid-Burgk J.L., Hemmerling I., Horvath G.L., Schmidt T., Latz E., et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 2013, 503:530-534.
84. Schoggins J.W., MacDuff D.A., Imanaka N., Gainey M.D., Shrestha B., Eitson J.L., et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 2014, 505:691-695.
85. Yount J.S., Moran T.M., Lopez C.B. Cytokine-independent upregulation of MDA5 in viral infection. J Virol 2007, 81:7316-7319.
86. Bego M.G., Mercier J., Cohen E.A. Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling. J Virol 2012, 86:3513-3527.